Bac-L

General Information


DRACP ID  DRACP02058

Peptide Name   Bac-L

Sequence  RLLRIVVIRVLR

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
RAW 264.7 Mouse macrophage leukemia cell Leukemia <20% Killing=400 µg/ml MTT assay 2 days 1

Hemolytic Activity  Human erythrocytes: <10% Hemolysis=400 µg/ml

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02058

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C69H132N24O13

Absent amino acids  ACDEFGHKMNPQSTWY

Common amino acids  R

Mass  170235

Pl  12.98

Basic residues  4

Acidic residues  0

Hydrophobic residues  8

Net charge  4

Boman Index  -2296

Hydrophobicity  125

Aliphatic Index  235

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23109411

Title  Linear bactenecin analogs with cell selectivity and anti-endotoxic activity

Doi 10.1002/psc.2460

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_13535

DRACP is developed by Dr.Zheng's team.